The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
| MRSKX | VFWPX | MRSKX / VFWPX | |
| Total Expense Ratio | 0.64 | 0.03 | 2,133% |
| Annual Report Gross Expense Ratio | 0.65 | 0.03 | 2,167% |
| Fund Existence | 20 years | 16 years | - |
| Gain YTD | 14.457 | 16.305 | 89% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | N/A | 100000000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 17.7B | 95.9B | 18% |
| Annual Yield % from dividends | 1.85 | 2.49 | 74% |
| Returns for 1 year | 17.29 | 24.30 | 71% |
| Returns for 3 years | 45.80 | 61.94 | 74% |
| Returns for 5 years | 28.11 | 38.55 | 73% |
| Returns for 10 years | 118.99 | 100.50 | 118% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| IAXIX | 8.44 | N/A | N/A |
| VY® T. Rowe Price Divers Mid Cap Gr I | |||
| MVGMX | 18.76 | N/A | N/A |
| MFS Low Volatility Global Equity R4 | |||
| JMVRX | 36.54 | N/A | N/A |
| JPMorgan Mid Cap Value R5 | |||
| LYFCX | 18.40 | N/A | N/A |
| AlphaCentric Life Sciences & Hlthcare C | |||
| TQCIX | 22.56 | N/A | N/A |
| Touchstone Dividend Equity Institutional | |||